|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5297 USD | -0.02% |
|
0.00% | +17.71% |
| 06/04 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 12/11 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 21.75L 19.11L 17.84L 16.37L 30.65L 21Cr 31.4L 2.12Cr 82.73L 10Cr 81.66L 79.88L 36Cr | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.35Cr 1.18Cr 1.11Cr 1.01Cr 1.9Cr 129.13Cr 1.95Cr 13Cr 5.13Cr 64Cr 5.06Cr 4.95Cr 220.91Cr | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -0.02% | ||
| Current month | +22.02% | ||
| 1 month | +1.98% | ||
| 3 months | +36.13% | ||
| 6 months | +11.52% | ||
| Current year | +17.71% |
| 1 month | 0.39 | 0.53 | |
| Current year | 0.23 | 0.55 | |
| 1 year | 0.21 | 0.57 | |
| 3 years | 0.12 | 1.04 | |
| 5 years | 0.12 | 3.95 | |
| 10 years | 0.12 | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.02% | 0.00% | +39.39% | -41.77% | 38.4L | ||
| -0.05% | +4.83% | +59.80% | +168.22% | 1,08900Cr | ||
| -0.00% | +4.19% | +58.44% | +58.99% | 64TCr | ||
| +1.34% | +5.08% | +39.20% | +77.94% | 47TCr | ||
| -1.69% | +8.81% | +39.38% | +33.67% | 36TCr | ||
| -0.51% | +3.51% | +36.97% | +42.46% | 30TCr | ||
| +1.50% | +3.40% | +17.71% | +17.41% | 27TCr | ||
| +0.79% | +5.81% | -2.55% | -38.10% | 23TCr | ||
| -0.86% | +6.44% | +28.35% | +66.40% | 21TCr | ||
| -0.03% | +2.96% | +17.48% | +76.25% | 17TCr | ||
| Average | +0.03% | +4.57% | +33.42% | +46.15% | 37.31TCr | |
| Weighted average by Cap. | +0.01% | +5.14% | +42.70% | +81.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.31Cr 2.03Cr 1.89Cr 1.74Cr 3.25Cr 220.98Cr 3.33Cr 22Cr 8.78Cr 109.35Cr 8.66Cr 8.47Cr 378.03Cr | 2.42Cr 2.13Cr 1.99Cr 1.82Cr 3.41Cr 231.94Cr 3.5Cr 24Cr 9.21Cr 114.77Cr 9.09Cr 8.89Cr 396.77Cr |
| Net income | -52.67L -46.28L -43.2L -39.65L -74.22L -50Cr -76.04L -5.12Cr -2Cr -25Cr -1.98Cr -1.93Cr -86Cr | -32.03L -28.14L -26.27L -24.11L -45.13L -31Cr -46.24L -3.12Cr -1.22Cr -15Cr -1.2Cr -1.18Cr -52Cr |
| Net Debt | 1.02Cr 89.6L 83.64L 76.76L 1.44Cr 98Cr 1.47Cr 9.92Cr 3.88Cr 48Cr 3.83Cr 3.75Cr 167.08Cr | 1.13Cr 99.35L 92.74L 85.11L 1.59Cr 108.3Cr 1.63Cr 11Cr 4.3Cr 54Cr 4.25Cr 4.15Cr 185.27Cr |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | $0.5297 | -0.02% | 12,014 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions

















